SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cell Therapeutics (CTIC) -- Ignore unavailable to you. Want to Upgrade?

To: Icebrg who wrote (510)3/7/2005 8:43:13 AM
From: tom pope  Respond to of 946
 
Just posting this for our possible wry amusement - Garren on LGND:

The longer LGND waits before releasing data the more positive the trials prospects look since it could mean that fewer patients are dying early in the Targretin arms

yeah, that's what some thought about Xyotax.

All my CTIC are hedged (?) with the Mar calls, but the hedge seems a bit leaky so far.



To: Icebrg who wrote (510)3/7/2005 11:20:09 AM
From: tuck  Read Replies (2) | Respond to of 946
 
If XYOTAX flops, you reckon they'll have to have to finance again to advance Pixantrone? Having unloaded some, I was going to buy after the above event, but am now thinking of doing so in two chunks. One about now, and another on news of financing.

TIA & Cheers, Tuck


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News